Bayer Aktiengesellschaft (BAYRY)
OTCMKTS: BAYRY · Delayed Price · USD
6.91
-0.07 (-1.00%)
Jul 2, 2024, 3:55 PM EDT - Market closed
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 47.01B EUR in the twelve months ending March 31, 2024, down -6.88% year-over-year. Revenue in the quarter ending March 31, 2024 was 13.77B EUR, a -4.34% decrease year-over-year. In the year 2023, Bayer Aktiengesellschaft had annual revenue of 47.64B EUR, a decrease of -6.11%.
Revenue (ttm)
47.01B EUR
Revenue Growth
-6.88%
P/S Ratio
0.54
Revenue / Employee
478,801 EUR
Employees
98,189
Market Cap
27.15B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | 43.55B | 3.96B | 10.00% |
Dec 31, 2018 | 39.59B | 4.57B | 13.05% |
Dec 31, 2017 | 35.02B | -11.75B | -25.13% |
Dec 31, 2016 | 46.77B | 445.00M | 0.96% |
Dec 31, 2015 | 46.32B | 4.09B | 9.67% |
Dec 31, 2014 | 42.24B | 2.08B | 5.18% |
Dec 31, 2013 | 40.16B | 397.00M | 1.00% |
Dec 31, 2012 | 39.76B | 3.23B | 8.85% |
Dec 31, 2011 | 36.53B | 1.44B | 4.10% |
Dec 31, 2010 | 35.09B | 3.92B | 12.58% |
Dec 31, 2009 | 31.17B | -1.75B | -5.32% |
Dec 31, 2008 | 32.92B | 533.00M | 1.65% |
Dec 31, 2007 | 32.39B | 3.43B | 11.84% |
Dec 31, 2006 | 28.96B | 1.59B | 5.82% |
Dec 31, 2005 | 27.36B | -2.37B | -7.98% |
Dec 31, 2004 | 29.74B | 1.22B | 4.27% |
Dec 31, 2003 | 28.52B | -467.00M | -1.61% |
Dec 31, 2002 | 28.98B | -3.30M | -0.01% |
Dec 31, 2001 | 28.99B | -573.55M | -1.94% |
Dec 31, 2000 | 29.56B | 2.24B | 8.20% |
Dec 31, 1999 | 27.32B | -742.00M | -2.64% |
Dec 31, 1998 | 28.06B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
BAYRY News
- 5 days ago - Bayer and Rad AI Announce Collaboration agreement - Business Wire
- 6 days ago - Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia - Reuters
- 9 days ago - Bayer and Solynta Collaborate to Advance True Potato Seed in Smallholder Markets - Business Wire
- 14 days ago - Bayer looks to AI to combat herbicide resistance faster - Reuters
- 4 weeks ago - Judge cuts Bayer $2.25 billion Roundup verdict to $400 million - Reuters
- 6 weeks ago - Bayer, maker of Roundup weedkiller, steps up fight against cancer-related lawsuits - Market Watch
- 6 weeks ago - Bayer presents latest data from oncology portfolio at 2024 ASCO Annual Meeting - Business Wire
- 6 weeks ago - Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer - Business Wire